Home › Acute Kidney Injury › New York
Acute Kidney Injury clinical trials in New York
8 studies for Acute Kidney Injury are looking for participants at sites in New York.
Cities in New York
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
- The Mount Sinai Hospital, New York
- Stony Brook University Hospital, Stony Brook
Recruiting
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT05758077A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
- Research Site, The Bronx
- Research Site, The Bronx
- Research Site, The Bronx
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07215702Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
- Columbia University Irving Medical Center, New York
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Aug 19, 2026 · NCT06937307The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
- Bassett Medical Center, Cooperstown
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07556107Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Mount Sinai Medical Center, New York
- Jacobi Medical Center, The Bronx
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Aug 14, 2026 · NCT06699849Kidney Precision Medicine Project
- Mount Sinai, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT04334707NIRS Monitoring in the NICU and AKI
- NYU Langone Health, New York
RecruitingHealthy volunteers welcome
24 Weeks – 30 Weeks · All sexes · Updated Oct 30, 2025 · NCT07222722Nafamostat Efficacy in Phase 3 Registrational CRRT Study
- Northwell Health, Great Neck
- Mount Sinai, New York
Recruiting
Ages 18 to 80 · All sexes · Updated Oct 15, 2025 · NCT06150742From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.